OTO — Otofarma SpA Income Statement
0.000.00%
Last trade - 00:00- €12.49m
- €6.71m
- €15.95m
Annual income statement for Otofarma SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 15.1 | 16 |
| Cost of Revenue | ||
| Gross Profit | 5.88 | 4.7 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 13.1 | 16.8 |
| Operating Profit | 1.94 | -0.81 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | 1.68 | -0.967 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 0.695 | -1.3 |
| Minority Interest | ||
| Net Income Before Extraordinary Items | ||
| Net Income | 0.699 | -1.51 |
| Adjustments to Net Income | ||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 0.698 | -1.51 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 0.157 | -0.17 |